Literature DB >> 26116921

EuroSCORE II underestimates mortality after cardiac surgery for infective endocarditis.

Soléne Patrat-Delon1, Adrien Rouxel2, Arnaud Gacouin1, Matthieu Revest1, Erwan Flécher3, Olivier Fouquet4, Yves Le Tulzo1, Nicolas Lerolle2, Pierre Tattevin1, Jean-Marc Tadié5.   

Abstract

OBJECTIVES: To better select for patients who most likely will benefit from cardiac surgery among those with infective endocarditis (IE), we aimed to identify preoperative markers associated with poor outcome after cardiac surgery for IE, and to evaluate the accuracy of European System for Cardiac Operative Risk Evaluation (EuroSCORE) II to predict mortality.
METHODS: We enrolled all adult patients who underwent cardiac surgery during the acute phase of definite IE (Duke Criteria) in two referral centres for cardiac surgery. Patients were identified through intensive care unit (ICU) electronic databases, and data were collected from medical charts on standardized questionnaire.
RESULTS: Between 2002 and 2013, 149 patients (117 males), with a median age of 64 years [interquartile range 52-73], fulfilled the inclusion criteria. Main complications before surgery were left ventricular dysfunction (23%), central nervous system symptomatic events (34%) and septic shock (24%). Most patients (95%) presented with valve regurgitation, and 49% had perivalvular abscess. Surgery was performed with a median delay of 12 days [5-24] after IE diagnosis, and mean EuroSCORE II was 15.8 (13.4-18.1). In-hospital mortality was 21%. Preoperative variables associated with mortality in multivariate analysis were obesity [odds ratio (OR) 3.67 [1.10-12.19], P = 0.03], vegetation >15 mm (OR 6.72 [1.46-30.98], P = 0.01), septic shock (OR 4.87 [1.67-14.28], P = 0.004) and mechanical prosthetic valve IE (OR 4.99 [1.72-28.57], P = 0.007). EuroSCORE II underestimated mortality in patients with predicted mortality over 10%.
CONCLUSION: Factors independently predictive of mortality after cardiac surgery for IE are obesity, septic shock, large vegetation and a mechanical prosthetic valve IE. EuroSCORE II underestimates post-cardiac surgery mortality in patients with IE.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  EuroSCORE II; Infective endocarditis; Mortality; Surgery

Mesh:

Year:  2015        PMID: 26116921     DOI: 10.1093/ejcts/ezv223

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system.

Authors:  Giuseppe Gatti; Bernardo Benussi; Florida Gripshi; Alessio Della Mattia; Alberto Proclemer; Antonio Cannatà; Lorella Dreas; Roberto Luzzati; Gianfranco Sinagra; Aniello Pappalardo
Journal:  Infection       Date:  2017-01-04       Impact factor: 3.553

2.  Determinants and consequences of positive valve culture when cardiac surgery is performed during the acute phase of infective endocarditis.

Authors:  P Fillâtre; A Gacouin; M Revest; A Maamar; S Patrat-Delon; E Flécher; O Fouquet; N Lerolle; J-P Verhoye; Y Le Tulzo; Pierre Tattevin; J-M Tadié
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-26       Impact factor: 3.267

3.  Should we include microorganisms in scores to predict outcome in candidates for cardiac surgery during the acute phase of endocarditis?

Authors:  Pierre Tattevin; Pierre Fillâtre; Serge Tchamgoué; Mathieu Lesouhaitier; Nicolas Nesseler; Jean-Marc Tadié
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 4.  Neurologic Complications of Infective Endocarditis: Recent Findings.

Authors:  Marie Cantier; Mikael Mazighi; Isabelle Klein; J P Desilles; Michel Wolff; J F Timsit; Romain Sonneville
Journal:  Curr Infect Dis Rep       Date:  2017-09-19       Impact factor: 3.725

5.  Machine Learning-Based Risk Model for Predicting Early Mortality After Surgery for Infective Endocarditis.

Authors:  Li Luo; Sui-Qing Huang; Chuang Liu; Quan Liu; Shuohui Dong; Yuan Yue; Kai-Zheng Liu; Lin Huang; Shun-Jun Wang; Hua-Yang Li; Shaoyi Zheng; Zhong-Kai Wu
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

6.  Assessment of three risk evaluation systems for patients aged ≥70 in East China: performance of SinoSCORE, EuroSCORE II and the STS risk evaluation system.

Authors:  Lingtong Shan; Wen Ge; Yiwei Pu; Hong Cheng; Zhengqiang Cang; Xing Zhang; Qifan Li; Anyang Xu; Qi Wang; Chang Gu; Yangyang Zhang
Journal:  PeerJ       Date:  2018-02-23       Impact factor: 2.984

7.  Use of Smart Technology for the Early Diagnosis of Complications After Cardiac Surgery: The Box 2.0 Study Protocol.

Authors:  Tom E Biersteker; Mark J Boogers; Robert Af de Lind van Wijngaarden; Rolf Hh Groenwold; Serge A Trines; Anouk P van Alem; Charles Jhj Kirchhof; Nicolette van Hof; Robert Jm Klautz; Martin J Schalij; Roderick W Treskes
Journal:  JMIR Res Protoc       Date:  2020-04-21

8.  A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort.

Authors:  Ho Jin Kim; Joon Bum Kim; Seon-Ok Kim; Sung-Cheol Yun; Sak Lee; Cheong Lim; Jae Woong Choi; Ho Young Hwang; Kyung Hwan Kim; Seung Hyun Lee; Jae Suk Yoo; Kiick Sung; Hyung Gon Je; Soon Chang Hong; Yun Jung Kim; Sung-Hyun Kim; Byung-Chul Chang
Journal:  J Chest Surg       Date:  2021-04-05

9.  Simple Scoring System to Predict In-Hospital Mortality After Surgery for Infective Endocarditis.

Authors:  Giuseppe Gatti; Andrea Perrotti; Jean-François Obadia; Xavier Duval; Bernard Iung; François Alla; Catherine Chirouze; Christine Selton-Suty; Bruno Hoen; Gianfranco Sinagra; François Delahaye; Pierre Tattevin; Vincent Le Moing; Aniello Pappalardo; Sidney Chocron
Journal:  J Am Heart Assoc       Date:  2017-07-20       Impact factor: 5.501

10.  Analysis of Risk Scores to Predict Mortality in Patients Undergoing Cardiac Surgery for Endocarditis.

Authors:  Fernando Pivatto Júnior; Clarissa Carmona de Azevedo Bellagamba; Eduardo Gatti Pianca; Fernando Schmidt Fernandes; Maurício Butzke; Stefano Boemler Busato; Miguel Gus
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.